Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6206 results
prostate cancer biopsy
  • Science & Technology
  • Health & Medicine

Targeted prostate cancer screening: Are we there yet?

Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet? Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?

by Katie Roberts | Analysis | 20 October 2021

20 October 2021

3D representation of oesophageal cancer

The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer. The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.

by Harry Jenkins | News | 20 October 2021

20 October 2021

We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub… We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…

by Phil Prime | Interview | 15 October 2021

15 October 2021

We hear from Rosie Lomas - the 'Excellence in Cancer Research Nursing Award' winner - and the other shortlisted nurses about their work and the vital role they play in delivering clinical trials. We hear from Rosie Lomas - the 'Excellence in Cancer Research Nursing Award' winner - and the other shortlisted nurses about their work and the vital role they play in delivering clinical trials.

by Cancer Research UK | In depth | 13 October 2021

13 October 2021

Elaine with husband Kilian

Elaine Whelan has pledged 10% of her estate to help fuel the research of tomorrow. Here, she tells us why she chose to support our work with a significant gift in her Will. Elaine Whelan has pledged 10% of her estate to help fuel the research of tomorrow. Here, she tells us why she chose to support our work with a significant gift in her Will.

by Michael Geraghty | Interview | 13 October 2021

13 October 2021

Cath standing outside parliament

We spoke to 4 people about why, when it comes to cancer, every second counts and why the Government must act now to ensure the NHS can catch more cancers early. We spoke to 4 people about why, when it comes to cancer, every second counts and why the Government must act now to ensure the NHS can catch more cancers early.

by Katie Roberts | In depth | 11 October 2021

11 October 2021

That Cancer Conversation in a white speech bubble with a dark blue background

From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer. From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer.

by Cancer Research UK | Podcast | 8 October 2021

8 October 2021

This entry is part 3 of 37 in the series That Cancer Conversation
%postcontent%
Cytosponge

Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers... Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers...

by Phil Prime | Interview | 7 October 2021

7 October 2021

  • For Researchers
  • Science & Technology

Delivering the future of paediatric brain tumour therapy

Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough… Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough…

by Phil Prime | Research Feature | 7 October 2021

7 October 2021